Pfizer 1Q Revenues: $11.4 billion (-9%) 1Q Earnings: $2.3 billion (-15%) Comments: Global Vaccines sales were flat at $925 million in the quarter. Consumer Healthcare sales were down 6% to $761 million. Global Oncology revenue was $488 million, up 7%, driven by Xalkori (+66% to $88 million) and Inlyta (+40% to $88 million). Lyrica sales were $1.2 billion, up 8%. Alliance revenue was down 71% to $213 million.Sales declines were attributed to the expiration of the co-promotion term for Enbrel i...